Perspective Therapeutics, Inc. (CATX) Form 10-Q Quarterly Reports
Perspective Therapeutics, Inc. (CATX) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CATX
CIK: 728387
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
WithumSmith+Brown, PC
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerDouglas Pallotta
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-08 | 2026-10-08 | 8-K | 0001193125-26-417384 | View SEC Doc Filr Page |
| 8-K | 2026-10-01 | 2026-10-01 | 8-K | 0001193125-26-410663 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-23 | — | SCHEDULE 13D/A Filing | 0001193125-26-399446 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | 8-K | 0001193125-26-389785 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | 8-K | 0001193125-26-385362 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-03 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000318 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000316 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-08-31 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000314 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-04 | — | SCHEDULE 13D/A Filing | 0001193125-26-383775 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000310 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0002064832-26-000308 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001104659-26-096145 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001193125-26-342512 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-342495 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000524 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001193125-26-330599 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-29 | — | SCHEDULE 13G Filing | 0002012383-26-002804 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-20 | — | SCHEDULE 13G Filing | 0001104659-26-085110 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-07-01 | 8-K | 0001193125-26-292547 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-30 | — | SCHEDULE 13G Filing | 0001104659-26-079425 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-06-01 | 8-K | 0001193125-26-249594 | View SEC Doc Filr Page |
| 8-K | 2026-05-27 | 2026-05-27 | 8-K | 0001193125-26-241940 | View SEC Doc Filr Page |
| 8-K | 2026-05-22 | 2026-05-21 | 8-K | 0001193125-26-234991 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-12 | — | SCHEDULE 13G/A Filing | 0000895421-26-000172 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | 10-Q | 0001193125-26-216790 | View SEC Doc Filr Page |